Susanne E. Churchill, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2019 | 4558 | 0.660 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2019 | 2389 | 0.490 |
Why?
|
| Personal Autonomy | 1 | 2016 | 298 | 0.460 |
Why?
|
| Colitis, Ulcerative | 8 | 2019 | 1899 | 0.420 |
Why?
|
| Crohn Disease | 8 | 2019 | 2243 | 0.410 |
Why?
|
| Natural Language Processing | 10 | 2019 | 1080 | 0.370 |
Why?
|
| Health Education | 1 | 2016 | 1045 | 0.340 |
Why?
|
| Algorithms | 16 | 2021 | 13796 | 0.330 |
Why?
|
| Information Storage and Retrieval | 6 | 2019 | 816 | 0.300 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 599 | 0.290 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2015 | 3734 | 0.240 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 3960 | 0.220 |
Why?
|
| Antidepressive Agents | 5 | 2016 | 2864 | 0.210 |
Why?
|
| Vitamin D | 4 | 2015 | 3239 | 0.180 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 290 | 0.180 |
Why?
|
| Depressive Disorder, Major | 5 | 2014 | 4682 | 0.150 |
Why?
|
| Depressive Disorder | 4 | 2016 | 3716 | 0.150 |
Why?
|
| Phenotype | 9 | 2019 | 16245 | 0.150 |
Why?
|
| Clostridium Infections | 2 | 2014 | 554 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4335 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2013 | 2044 | 0.120 |
Why?
|
| Suicide, Attempted | 1 | 2023 | 1232 | 0.120 |
Why?
|
| Hospitalization | 5 | 2014 | 10329 | 0.120 |
Why?
|
| Cohort Studies | 18 | 2016 | 40503 | 0.120 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 498 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 925 | 0.110 |
Why?
|
| Vitamin D Deficiency | 2 | 2013 | 1356 | 0.110 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 234 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 2439 | 0.110 |
Why?
|
| Pregnancy, Animal | 3 | 1982 | 125 | 0.100 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 429 | 0.100 |
Why?
|
| Confidentiality | 2 | 2019 | 607 | 0.100 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
| Data Mining | 1 | 2017 | 545 | 0.100 |
Why?
|
| Adult | 32 | 2016 | 214958 | 0.100 |
Why?
|
| Sex Ratio | 1 | 2012 | 106 | 0.100 |
Why?
|
| Biomedical Research | 3 | 2013 | 3327 | 0.100 |
Why?
|
| Systems Integration | 2 | 2011 | 428 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2677 | 0.100 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 332 | 0.100 |
Why?
|
| Software | 4 | 2014 | 4399 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 491 | 0.100 |
Why?
|
| Sjogren's Syndrome | 1 | 2013 | 234 | 0.090 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 6746 | 0.090 |
Why?
|
| Parturition | 1 | 2014 | 435 | 0.090 |
Why?
|
| Male | 39 | 2016 | 351093 | 0.090 |
Why?
|
| New England | 4 | 2014 | 1027 | 0.090 |
Why?
|
| Logistic Models | 9 | 2015 | 13164 | 0.090 |
Why?
|
| Female | 42 | 2016 | 382109 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 635 | 0.090 |
Why?
|
| Boston | 5 | 2016 | 9209 | 0.090 |
Why?
|
| Ethanol | 1 | 2016 | 1316 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2685 | 0.090 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 16 | 0.090 |
Why?
|
| Medical Informatics Applications | 1 | 2011 | 179 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 3666 | 0.090 |
Why?
|
| Limbic System | 1 | 2012 | 415 | 0.090 |
Why?
|
| Middle Aged | 29 | 2016 | 214412 | 0.080 |
Why?
|
| Humans | 55 | 2023 | 746044 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1567 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2013 | 881 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 264 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2013 | 662 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2014 | 1003 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 915 | 0.070 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2007 | 65 | 0.070 |
Why?
|
| Risk Factors | 16 | 2016 | 72416 | 0.070 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 398 | 0.070 |
Why?
|
| Accidental Falls | 1 | 2014 | 1034 | 0.070 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5764 | 0.070 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2007 | 165 | 0.070 |
Why?
|
| Telemedicine | 1 | 2023 | 2892 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1355 | 0.070 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1197 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2013 | 728 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2010 | 1404 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2014 | 1366 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2013 | 875 | 0.060 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 2 | 1996 | 7 | 0.060 |
Why?
|
| ROC Curve | 3 | 2023 | 3496 | 0.060 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12202 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 1998 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2678 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 1958 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2014 | 3423 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2310 | 0.060 |
Why?
|
| International Classification of Diseases | 3 | 2018 | 868 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12018 | 0.060 |
Why?
|
| Kidney | 4 | 1991 | 6982 | 0.060 |
Why?
|
| Genotype | 6 | 2015 | 12773 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1188 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7699 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17434 | 0.050 |
Why?
|
| Young Adult | 8 | 2016 | 57106 | 0.050 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 684 | 0.050 |
Why?
|
| Case-Control Studies | 7 | 2014 | 21673 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2224 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2016 | 23453 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2244 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3290 | 0.050 |
Why?
|
| Aldosterone | 3 | 1991 | 861 | 0.050 |
Why?
|
| Adolescent | 6 | 2016 | 86202 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3751 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 2409 | 0.050 |
Why?
|
| Health Services Research | 1 | 2009 | 1810 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2348 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 39587 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 10351 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3269 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 38752 | 0.050 |
Why?
|
| Bipolar Disorder | 2 | 2014 | 5051 | 0.040 |
Why?
|
| Prognosis | 6 | 2016 | 29068 | 0.040 |
Why?
|
| Sodium | 3 | 1982 | 1604 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6320 | 0.040 |
Why?
|
| Diuresis | 2 | 1991 | 111 | 0.040 |
Why?
|
| Aged | 14 | 2016 | 164236 | 0.040 |
Why?
|
| Psychiatry | 1 | 2011 | 1683 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15537 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 15308 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3132 | 0.040 |
Why?
|
| Incidence | 5 | 2014 | 20812 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4732 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 2372 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 9443 | 0.040 |
Why?
|
| Urine | 3 | 1991 | 354 | 0.040 |
Why?
|
| Genomics | 2 | 2011 | 5694 | 0.040 |
Why?
|
| Risk | 3 | 2015 | 9520 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2016 | 41376 | 0.030 |
Why?
|
| Registries | 1 | 2012 | 8170 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 779 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 19804 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6454 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 186 | 0.030 |
Why?
|
| Blood Volume | 2 | 1991 | 551 | 0.030 |
Why?
|
| Unified Medical Language System | 1 | 2015 | 87 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 21688 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 79 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1996 | 406 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 111 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 2014 | 73 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1601 | 0.030 |
Why?
|
| United States | 7 | 2019 | 70383 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 167 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 6056 | 0.030 |
Why?
|
| England | 1 | 2014 | 515 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3954 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 453 | 0.030 |
Why?
|
| Potassium | 2 | 1991 | 1313 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 334 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
| Pregnancy | 6 | 2016 | 29294 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 664 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9596 | 0.030 |
Why?
|
| Bupropion | 1 | 2014 | 302 | 0.030 |
Why?
|
| Fornix, Brain | 1 | 2012 | 70 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2012 | 5092 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 25752 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2013 | 195 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 387 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1490 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1991 | 341 | 0.020 |
Why?
|
| Citalopram | 1 | 2014 | 399 | 0.020 |
Why?
|
| Natriuresis | 1 | 1991 | 124 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 296 | 0.020 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2011 | 95 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 509 | 0.020 |
Why?
|
| Sample Size | 1 | 2014 | 832 | 0.020 |
Why?
|
| Child | 3 | 2016 | 78456 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2019 | 2272 | 0.020 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 393 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 485 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15341 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1647 | 0.020 |
Why?
|
| Kinetics | 3 | 1996 | 6352 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 776 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 35444 | 0.020 |
Why?
|
| Computer Systems | 1 | 2011 | 471 | 0.020 |
Why?
|
| Causality | 1 | 2016 | 1232 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 927 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 573 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 672 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12273 | 0.020 |
Why?
|
| Anisotropy | 1 | 2012 | 1272 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 946 | 0.020 |
Why?
|
| Methotrexate | 1 | 2015 | 1717 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3426 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1412 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 1149 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 319 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 849 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 25177 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13303 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15009 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 126 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 1987 | 179 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 668 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 1848 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2361 | 0.020 |
Why?
|
| Goals | 1 | 2011 | 693 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1781 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7810 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 953 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1510 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1101 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 26596 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6459 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4313 | 0.020 |
Why?
|
| Vasopressins | 1 | 1987 | 367 | 0.020 |
Why?
|
| Extremities | 1 | 1991 | 849 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 35784 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2014 | 78297 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1996 | 4163 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 6831 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2011 | 3532 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6453 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15366 | 0.010 |
Why?
|
| Rats | 5 | 1996 | 23680 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53218 | 0.010 |
Why?
|
| Forecasting | 1 | 2011 | 2905 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 5982 | 0.010 |
Why?
|
| Kidney Tubules, Distal | 1 | 1982 | 45 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1951 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8593 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6146 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6453 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2014 | 3174 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2717 | 0.010 |
Why?
|
| Urodynamics | 1 | 1982 | 347 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2012 | 63661 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1982 | 396 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12632 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14537 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8370 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3548 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4175 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10279 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2701 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1996 | 3601 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1981 | 556 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 57557 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3494 | 0.010 |
Why?
|
| Spironolactone | 1 | 1981 | 398 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12633 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 176 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 8901 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 14113 | 0.010 |
Why?
|
| Animals | 7 | 1996 | 166331 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 6931 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 683 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1753 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1993 | 74 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 7826 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1993 | 79 | 0.010 |
Why?
|
| Liposomes | 1 | 1996 | 778 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1223 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 6109 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1980 | 4187 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1993 | 1993 | 0.010 |
Why?
|
| Phospholipids | 1 | 1993 | 774 | 0.010 |
Why?
|
| NAD | 1 | 1993 | 594 | 0.010 |
Why?
|
| Homeostasis | 1 | 1980 | 3260 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 3959 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 15308 | 0.000 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1987 | 90 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6508 | 0.000 |
Why?
|
| Tyrosine | 1 | 1987 | 1441 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7580 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1980 | 568 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1980 | 468 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7370 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 1501 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1980 | 2142 | 0.000 |
Why?
|